Group One Trading, L.P. Bio N Tech Se Transaction History

Group One Trading, L.P.

  • $2.2 Billion
  • Q1 2025

A detailed history of Group One Trading, L.P. transactions in Bio N Tech Se stock. As of the latest transaction made, Group One Trading, L.P. holds 63,304 shares of BNTX stock, worth $6.07 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
63,304
Previous 66,072 4.19%
Holding current value
$6.07 Million
Previous $7.53 Million 23.43%
% of portfolio
0.26%
Previous 0.28%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$91.06 - $126.88 $252,054 - $351,203
-2,768 Reduced 4.19%
63,304 $5.76 Million
Q4 2024

Feb 14, 2025
BUY
$99.72 - $122.68 $5.05 Million - $6.21 Million
50,615 Added 327.46%
66,072 $7.53 Million
Q3 2024

Nov 14, 2024
SELL
$78.36 - $124.66 $2.96 Million - $4.72 Million
-37,834 Reduced 71.0%
15,457 $1.84 Million
Q2 2024

Aug 14, 2024
BUY
$80.36 - $102.87 $504,017 - $645,200
6,272 Added 13.34%
53,291 $4.28 Million
Q1 2024

May 10, 2024
SELL
$88.96 - $112.35 $439,996 - $555,683
-4,946 Reduced 9.52%
47,019 $4.34 Million
Q4 2023

Feb 14, 2024
SELL
$90.91 - $112.75 $1.97 Million - $2.44 Million
-21,615 Reduced 29.38%
51,965 $5.48 Million
Q3 2023

Nov 09, 2023
BUY
$98.5 - $125.08 $4.31 Million - $5.47 Million
43,770 Added 146.83%
73,580 $7.99 Million
Q2 2023

Aug 09, 2023
BUY
$102.58 - $129.66 $76,114 - $96,207
742 Added 2.55%
29,810 $3.22 Million
Q1 2023

May 12, 2023
SELL
$122.57 - $153.67 $2.52 Million - $3.16 Million
-20,547 Reduced 41.41%
29,068 $3.62 Million
Q4 2022

Feb 09, 2023
SELL
$118.43 - $186.05 $43,937 - $69,024
-371 Reduced 0.74%
49,615 $7.45 Million
Q3 2022

Nov 09, 2022
SELL
$127.65 - $183.11 $5.84 Million - $8.38 Million
-45,789 Reduced 47.81%
49,986 $6.74 Million
Q2 2022

Aug 11, 2022
SELL
$123.25 - $186.24 $13.7 Million - $20.7 Million
-111,243 Reduced 53.74%
95,775 $14.3 Million
Q1 2022

May 12, 2022
BUY
$126.25 - $231.85 $7.5 Million - $13.8 Million
59,384 Added 40.22%
207,018 $35.3 Million
Q4 2021

Feb 11, 2022
BUY
$216.64 - $362.52 $11.7 Million - $19.6 Million
53,992 Added 57.66%
147,634 $38.1 Million
Q3 2021

Nov 12, 2021
BUY
$205.93 - $447.23 $5.9 Million - $12.8 Million
28,651 Added 44.08%
93,642 $25.6 Million
Q2 2021

Aug 10, 2021
SELL
$113.32 - $241.49 $492,262 - $1.05 Million
-4,344 Reduced 6.27%
64,991 $14.6 Million
Q1 2021

May 12, 2021
BUY
$85.73 - $119.5 $4.45 Million - $6.2 Million
51,874 Added 297.08%
69,335 $7.57 Million
Q4 2020

Feb 10, 2021
BUY
$72.71 - $129.54 $912,437 - $1.63 Million
12,549 Added 255.48%
17,461 $1.42 Million
Q3 2020

Nov 12, 2020
SELL
$57.81 - $104.17 $221,123 - $398,450
-3,825 Reduced 43.78%
4,912 $340,000
Q2 2020

Aug 13, 2020
BUY
$38.58 - $66.74 $337,073 - $583,107
8,737 New
8,737 $583,000

Others Institutions Holding BNTX

# of Institutions
340
Shares Held
40M
Call Options Held
1.43M
Put Options Held
1.54M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $23.3B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email